Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) was upgraded by equities researchers at Citizens Jmp from a "hold" rating to a "strong-buy" rating in a research note issued on Tuesday,Zacks.com reports.
SBRA has been the topic of a number of other reports. Scotiabank lifted their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a report on Friday, October 11th. Mizuho restated a "neutral" rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Citigroup upgraded Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their price target for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, JMP Securities raised Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price objective for the company in a research report on Tuesday. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $19.25.
Check Out Our Latest Stock Analysis on Sabra Health Care REIT
Sabra Health Care REIT Trading Up 2.3 %
Shares of NASDAQ SBRA traded up $0.38 during mid-day trading on Tuesday, reaching $17.18. 2,442,943 shares of the company's stock were exchanged, compared to its average volume of 1,765,283. The company's 50-day moving average is $18.05 and its 200-day moving average is $17.44. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 41.90, a PEG ratio of 2.20 and a beta of 1.26. Sabra Health Care REIT has a 52-week low of $12.83 and a 52-week high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The firm had revenue of $178.00 million for the quarter, compared to analysts' expectations of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter last year, the business earned $0.34 earnings per share. Analysts expect that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.
Institutional Investors Weigh In On Sabra Health Care REIT
A number of large investors have recently added to or reduced their stakes in the business. Quarry LP acquired a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $30,000. Assetmark Inc. grew its stake in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,231 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in Sabra Health Care REIT in the 3rd quarter valued at $59,000. Harbor Capital Advisors Inc. purchased a new position in shares of Sabra Health Care REIT during the 3rd quarter worth $78,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Sabra Health Care REIT by 25.3% during the third quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust's stock worth $86,000 after purchasing an additional 932 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.
About Sabra Health Care REIT
(
Get Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Recommended Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.